Eli Health raises $12M Series A for instant hormone monitoring system
10 juin 2025Eli Health has closed a $12 million Series A funding round led by BDC Capital’s Thrive Venture Fund to accelerate deployment of its Hormometer, the instant hormone monitoring system that delivers results from saliva to mobile app within minutes. The New York-based company has raised $20 million to date and plans to launch its platform in beta this year, beginning with cortisol monitoring. The funding will support production scaling, additional biomarker development, and expansion of the company’s personalized health platform.
(En version anglaise seulement)
Lire la suite